# Fentanyl vs Dexmedetomidine for Arthriscopic Shoulder Intervention in Elderly.

> **NCT05577117** · EARLY_PHASE1 · COMPLETED · sponsor: **Cairo University** · enrollment: 36 (actual)

## Conditions studied

- Shoulder Lesions

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT05577117
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-03
- **Primary completion:** 2022-11-02
- **Final completion:** 2022-11-10
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2022-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05577117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05577117, "Fentanyl vs Dexmedetomidine for Arthriscopic Shoulder Intervention in Elderly.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05577117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*